| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | 5.18e-08 | 303 | 15 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 7.13e-08 | 562 | 15 | 7 | GO:0003712 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 9.34e-06 | 1160 | 15 | 7 | GO:0030674 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 2.60e-05 | 1356 | 15 | 7 | GO:0060090 | |
| GeneOntologyMolecularFunction | protein antigen binding | 6.28e-05 | 16 | 15 | 2 | GO:1990405 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 9.93e-05 | 20 | 15 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.10e-04 | 21 | 15 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.51e-04 | 739 | 15 | 5 | GO:0003682 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 2.42e-04 | 31 | 15 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 4.25e-04 | 41 | 15 | 2 | GO:0140463 | |
| GeneOntologyMolecularFunction | p53 binding | 1.49e-03 | 77 | 15 | 2 | GO:0002039 | |
| GeneOntologyMolecularFunction | transcription factor binding | 1.96e-03 | 753 | 15 | 4 | GO:0008134 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 3.57e-03 | 120 | 15 | 2 | GO:0008013 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 8.45e-03 | 187 | 15 | 2 | GO:0016922 | |
| GeneOntologyMolecularFunction | antigen binding | 8.72e-03 | 190 | 15 | 2 | GO:0003823 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.02e-02 | 206 | 15 | 2 | GO:0140030 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1.18e-02 | 1244 | 15 | 4 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 1.27e-02 | 1271 | 15 | 4 | GO:0000987 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 1.87e-02 | 775 | 15 | 3 | GO:0016746 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2.02e-02 | 1459 | 15 | 4 | GO:0000977 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 1.75e-06 | 1390 | 15 | 8 | GO:0045944 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription elongation by RNA polymerase II | 7.55e-06 | 54 | 15 | 3 | GO:0032968 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription, elongation | 1.15e-05 | 62 | 15 | 3 | GO:0032786 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 cell lineage commitment | 1.38e-05 | 8 | 15 | 2 | GO:2000330 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 1.90e-05 | 231 | 15 | 4 | GO:0006352 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 cell lineage commitment | 2.70e-05 | 11 | 15 | 2 | GO:2000328 | |
| GeneOntologyBiologicalProcess | regulation of transcription elongation by RNA polymerase II | 3.88e-05 | 93 | 15 | 3 | GO:0034243 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 4.36e-05 | 999 | 15 | 6 | GO:0071824 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 cell differentiation | 4.47e-05 | 14 | 15 | 2 | GO:2000321 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription elongation | 5.58e-05 | 105 | 15 | 3 | GO:0032784 | |
| GeneOntologyBiologicalProcess | positive regulation of cell fate commitment | 7.50e-05 | 18 | 15 | 2 | GO:0010455 | |
| GeneOntologyBiologicalProcess | transcription elongation by RNA polymerase II | 9.83e-05 | 127 | 15 | 3 | GO:0006368 | |
| GeneOntologyBiologicalProcess | T-helper 17 cell lineage commitment | 1.13e-04 | 22 | 15 | 2 | GO:0072540 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 type immune response | 1.24e-04 | 23 | 15 | 2 | GO:2000318 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription elongation | 1.43e-04 | 144 | 15 | 3 | GO:0006354 | |
| GeneOntologyBiologicalProcess | T-helper cell lineage commitment | 1.71e-04 | 27 | 15 | 2 | GO:0002295 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell lineage commitment | 2.27e-04 | 31 | 15 | 2 | GO:0043373 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper cell differentiation | 2.27e-04 | 31 | 15 | 2 | GO:0045624 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell lineage commitment | 2.57e-04 | 33 | 15 | 2 | GO:0002363 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 cell differentiation | 2.57e-04 | 33 | 15 | 2 | GO:2000319 | |
| GeneOntologyBiologicalProcess | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 2.90e-04 | 35 | 15 | 2 | GO:0043369 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 3.03e-04 | 186 | 15 | 3 | GO:0006367 | |
| GeneOntologyBiologicalProcess | T cell lineage commitment | 4.18e-04 | 42 | 15 | 2 | GO:0002360 | |
| GeneOntologyBiologicalProcess | DNA damage response | 4.37e-04 | 959 | 15 | 5 | GO:0006974 | |
| GeneOntologyBiologicalProcess | positive regulation of CD4-positive, alpha-beta T cell differentiation | 4.80e-04 | 45 | 15 | 2 | GO:0043372 | |
| GeneOntologyBiologicalProcess | T-helper 17 cell differentiation | 5.24e-04 | 47 | 15 | 2 | GO:0072539 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 type immune response | 5.24e-04 | 47 | 15 | 2 | GO:2000316 | |
| GeneOntologyBiologicalProcess | positive T cell selection | 6.66e-04 | 53 | 15 | 2 | GO:0043368 | |
| GeneOntologyBiologicalProcess | regulation of cell fate commitment | 6.66e-04 | 53 | 15 | 2 | GO:0010453 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 7.10e-04 | 249 | 15 | 3 | GO:0065004 | |
| GeneOntologyBiologicalProcess | regulation of T-helper cell differentiation | 7.70e-04 | 57 | 15 | 2 | GO:0045622 | |
| GeneOntologyBiologicalProcess | viral transcription | 7.97e-04 | 58 | 15 | 2 | GO:0019083 | |
| GeneOntologyBiologicalProcess | positive regulation of CD4-positive, alpha-beta T cell activation | 7.97e-04 | 58 | 15 | 2 | GO:2000516 | |
| GeneOntologyBiologicalProcess | T-helper 17 type immune response | 9.70e-04 | 64 | 15 | 2 | GO:0072538 | |
| GeneOntologyBiologicalProcess | positive regulation of alpha-beta T cell differentiation | 9.70e-04 | 64 | 15 | 2 | GO:0046638 | |
| GeneOntologyBiologicalProcess | T cell selection | 1.13e-03 | 69 | 15 | 2 | GO:0045058 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription initiation by RNA polymerase II | 1.16e-03 | 70 | 15 | 2 | GO:0060261 | |
| GeneOntologyBiologicalProcess | RNA polymerase II preinitiation complex assembly | 1.19e-03 | 71 | 15 | 2 | GO:0051123 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell differentiation | 1.26e-03 | 73 | 15 | 2 | GO:0043370 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription initiation | 1.40e-03 | 77 | 15 | 2 | GO:2000144 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 1.43e-03 | 317 | 15 | 3 | GO:1903039 | |
| GeneOntologyBiologicalProcess | cellular response to heat | 1.55e-03 | 81 | 15 | 2 | GO:0034605 | |
| GeneOntologyBiologicalProcess | regulation of transcription initiation by RNA polymerase II | 1.55e-03 | 81 | 15 | 2 | GO:0060260 | |
| GeneOntologyBiologicalProcess | canonical NF-kappaB signal transduction | 1.60e-03 | 330 | 15 | 3 | GO:0007249 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 1.64e-03 | 741 | 15 | 4 | GO:0006338 | |
| GeneOntologyBiologicalProcess | transcription preinitiation complex assembly | 1.70e-03 | 85 | 15 | 2 | GO:0070897 | |
| GeneOntologyBiologicalProcess | positive regulation of alpha-beta T cell activation | 1.86e-03 | 89 | 15 | 2 | GO:0046635 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription initiation | 1.95e-03 | 91 | 15 | 2 | GO:2000142 | |
| GeneOntologyBiologicalProcess | modulation by host of symbiont process | 1.95e-03 | 91 | 15 | 2 | GO:0051851 | |
| GeneOntologyBiologicalProcess | T-helper cell differentiation | 1.99e-03 | 92 | 15 | 2 | GO:0042093 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell differentiation | 2.03e-03 | 93 | 15 | 2 | GO:0046637 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell differentiation involved in immune response | 2.08e-03 | 94 | 15 | 2 | GO:0002294 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell differentiation involved in immune response | 2.12e-03 | 95 | 15 | 2 | GO:0002293 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell activation involved in immune response | 2.25e-03 | 98 | 15 | 2 | GO:0002287 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell activation | 2.34e-03 | 100 | 15 | 2 | GO:2000514 | |
| GeneOntologyBiologicalProcess | T cell differentiation involved in immune response | 2.49e-03 | 103 | 15 | 2 | GO:0002292 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 2.56e-03 | 389 | 15 | 3 | GO:0022409 | |
| GeneOntologyBiologicalProcess | viral gene expression | 2.78e-03 | 109 | 15 | 2 | GO:0019080 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to nucleus | 3.03e-03 | 114 | 15 | 2 | GO:1900182 | |
| GeneOntologyBiologicalProcess | chromatin organization | 3.29e-03 | 896 | 15 | 4 | GO:0006325 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell differentiation | 3.30e-03 | 119 | 15 | 2 | GO:0043367 | |
| GeneOntologyBiologicalProcess | response to heat | 3.41e-03 | 121 | 15 | 2 | GO:0009408 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 3.42e-03 | 906 | 15 | 4 | GO:0043009 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 3.75e-03 | 929 | 15 | 4 | GO:0009792 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 3.79e-03 | 447 | 15 | 3 | GO:1903037 | |
| GeneOntologyBiologicalProcess | biological process involved in interaction with symbiont | 4.22e-03 | 135 | 15 | 2 | GO:0051702 | |
| GeneOntologyCellularComponent | transcription regulator complex | 1.29e-06 | 596 | 14 | 6 | GO:0005667 | |
| GeneOntologyCellularComponent | mediator complex | 1.83e-06 | 37 | 14 | 3 | GO:0016592 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 1.21e-05 | 1377 | 14 | 7 | GO:0140513 | |
| GeneOntologyCellularComponent | transferase complex | 2.05e-05 | 963 | 14 | 6 | GO:1990234 | |
| GeneOntologyCellularComponent | core mediator complex | 1.34e-04 | 26 | 14 | 2 | GO:0070847 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.76e-03 | 94 | 14 | 2 | GO:0000123 | |
| GeneOntologyCellularComponent | chromatin | 2.06e-03 | 1480 | 14 | 5 | GO:0000785 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 2.15e-03 | 104 | 14 | 2 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.35e-03 | 109 | 14 | 2 | GO:1902493 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | 3.20e-03 | 972 | 14 | 4 | GO:0140535 | |
| GeneOntologyCellularComponent | nuclear chromosome | 1.22e-02 | 254 | 14 | 2 | GO:0000228 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.38e-02 | 272 | 14 | 2 | GO:0090575 | |
| GeneOntologyCellularComponent | nuclear body | 2.05e-02 | 903 | 14 | 3 | GO:0016604 | |
| MousePheno | abnormal myocardium compact layer morphology | 3.69e-05 | 67 | 14 | 3 | MP:0004056 | |
| MousePheno | lethality throughout fetal growth and development | 4.52e-05 | 435 | 14 | 5 | MP:0006208 | |
| MousePheno | abnormal blastocyst morphology | 9.96e-05 | 259 | 14 | 4 | MP:0004957 | |
| MousePheno | lethality throughout fetal growth and development, complete penetrance | 1.06e-04 | 263 | 14 | 4 | MP:0011099 | |
| MousePheno | ventricular hypoplasia | 1.19e-04 | 99 | 14 | 3 | MP:0000279 | |
| MousePheno | abnormal epicardium morphology | 1.26e-04 | 17 | 14 | 2 | MP:0003057 | |
| MousePheno | abnormal preimplantation embryo morphology | 1.40e-04 | 283 | 14 | 4 | MP:0014137 | |
| MousePheno | thin ventricular wall | 3.16e-04 | 138 | 14 | 3 | MP:0000280 | |
| MousePheno | postnatal lethality, incomplete penetrance | 3.45e-04 | 669 | 14 | 5 | MP:0011086 | |
| MousePheno | abnormal myocardial trabeculae morphology | 3.59e-04 | 144 | 14 | 3 | MP:0002189 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | 4.55e-04 | 1124 | 14 | 6 | MP:0011112 | |
| MousePheno | abnormal pluripotent precursor cell morphology | 7.84e-04 | 42 | 14 | 2 | MP:0002399 | |
| MousePheno | thin myocardium compact layer | 9.40e-04 | 46 | 14 | 2 | MP:0004057 | |
| MousePheno | abnormal renal tubule epithelium morphology | 1.02e-03 | 48 | 14 | 2 | MP:0009640 | |
| MousePheno | abnormal fetal cardiomyocyte proliferation | 1.02e-03 | 48 | 14 | 2 | MP:0003567 | |
| MousePheno | abnormal cardiac muscle tissue morphology | 1.12e-03 | 489 | 14 | 4 | MP:0010630 | |
| MousePheno | kidney atrophy | 1.25e-03 | 53 | 14 | 2 | MP:0004970 | |
| MousePheno | abnormal embryo development | 1.32e-03 | 1370 | 14 | 6 | MP:0001672 | |
| MousePheno | abnormal fetal cardiomyocyte physiology | 1.34e-03 | 55 | 14 | 2 | MP:0011390 | |
| MousePheno | abnormal heart ventricle wall thickness | 1.35e-03 | 227 | 14 | 3 | MP:0020135 | |
| Domain | Bromodomain_CS | 1.93e-04 | 26 | 15 | 2 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 3.95e-04 | 37 | 15 | 2 | PS00633 | |
| Domain | Bromodomain | 4.16e-04 | 38 | 15 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 4.85e-04 | 41 | 15 | 2 | PS50014 | |
| Domain | BROMO | 5.09e-04 | 42 | 15 | 2 | SM00297 | |
| Domain | Bromodomain | 5.09e-04 | 42 | 15 | 2 | IPR001487 | |
| Domain | - | 5.09e-04 | 42 | 15 | 2 | 1.20.920.10 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 5.60e-07 | 84 | 12 | 4 | M1008 | |
| Pathway | REACTOME_ADIPOGENESIS | 1.66e-06 | 110 | 12 | 4 | M48259 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 2.19e-06 | 118 | 12 | 4 | M27316 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 6.85e-05 | 98 | 12 | 3 | M48247 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 1.01e-04 | 18 | 12 | 2 | M26942 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 1.25e-04 | 120 | 12 | 3 | M48233 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 2.54e-04 | 757 | 12 | 5 | M27451 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 4.12e-04 | 36 | 12 | 2 | M633 | |
| Pathway | REACTOME_VIRAL_INFECTION_PATHWAYS | 5.35e-04 | 888 | 12 | 5 | M48034 | |
| Pathway | REACTOME_HEME_SIGNALING | 7.64e-04 | 49 | 12 | 2 | M41832 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 8.28e-04 | 51 | 12 | 2 | M665 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 9.62e-04 | 55 | 12 | 2 | M27001 | |
| Pathway | REACTOME_INFECTIOUS_DISEASE | 1.32e-03 | 1081 | 12 | 5 | M27548 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 1.55e-03 | 70 | 12 | 2 | M938 | |
| Pubmed | 2.48e-15 | 549 | 15 | 10 | 38280479 | ||
| Pubmed | 3.63e-09 | 8 | 15 | 3 | 10823961 | ||
| Pubmed | 5.27e-09 | 1103 | 15 | 8 | 34189442 | ||
| Pubmed | Composite co-activator ARC mediates chromatin-directed transcriptional activation. | 1.14e-07 | 23 | 15 | 3 | 10235267 | |
| Pubmed | TAZ suppresses NFAT5 activity through tyrosine phosphorylation. | 1.74e-07 | 2 | 15 | 2 | 23045390 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 4.81e-07 | 1294 | 15 | 7 | 30804502 | |
| Pubmed | Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged mice. | 5.21e-07 | 3 | 15 | 2 | 32544088 | |
| Pubmed | Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4. | 5.21e-07 | 3 | 15 | 2 | 30224758 | |
| Pubmed | Promoter-bound p300 complexes facilitate post-mitotic transmission of transcriptional memory. | 5.21e-07 | 3 | 15 | 2 | 24945803 | |
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 9590171 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 20676058 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 28262505 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 6.72e-07 | 167 | 15 | 4 | 20362541 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 8.96e-07 | 444 | 15 | 5 | 34795231 | |
| Pubmed | 9.38e-07 | 1429 | 15 | 7 | 35140242 | ||
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 9194565 | ||
| Pubmed | LPS-induced NFκB enhanceosome requires TonEBP/NFAT5 without DNA binding. | 1.04e-06 | 4 | 15 | 2 | 27118681 | |
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 30428346 | ||
| Pubmed | NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. | 1.04e-06 | 4 | 15 | 2 | 24875858 | |
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 12754253 | ||
| Pubmed | Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection. | 1.04e-06 | 4 | 15 | 2 | 35716662 | |
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 11912212 | ||
| Pubmed | Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment. | 1.73e-06 | 5 | 15 | 2 | 15572696 | |
| Pubmed | 2.12e-06 | 529 | 15 | 5 | 14621295 | ||
| Pubmed | 2.42e-06 | 1014 | 15 | 6 | 32416067 | ||
| Pubmed | 2.60e-06 | 6 | 15 | 2 | 11443112 | ||
| Pubmed | 2.60e-06 | 6 | 15 | 2 | 26871568 | ||
| Pubmed | 2.79e-06 | 65 | 15 | 3 | 22496869 | ||
| Pubmed | 2.92e-06 | 66 | 15 | 3 | 23275444 | ||
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 3.34e-06 | 69 | 15 | 3 | 28481362 | |
| Pubmed | 3.64e-06 | 7 | 15 | 2 | 16332960 | ||
| Pubmed | 4.40e-06 | 268 | 15 | 4 | 33640491 | ||
| Pubmed | 4.85e-06 | 8 | 15 | 2 | 27018634 | ||
| Pubmed | 4.85e-06 | 8 | 15 | 2 | 23752591 | ||
| Pubmed | 5.84e-06 | 83 | 15 | 3 | 28794006 | ||
| Pubmed | HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. | 7.80e-06 | 10 | 15 | 2 | 23746844 | |
| Pubmed | 9.93e-06 | 99 | 15 | 3 | 34161765 | ||
| Pubmed | 1.14e-05 | 12 | 15 | 2 | 12189208 | ||
| Pubmed | 1.18e-05 | 754 | 15 | 5 | 35906200 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.27e-05 | 351 | 15 | 4 | 38297188 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 1.36e-05 | 357 | 15 | 4 | 37059091 | |
| Pubmed | 2.08e-05 | 16 | 15 | 2 | 23870121 | ||
| Pubmed | 2.25e-05 | 130 | 15 | 3 | 12421765 | ||
| Pubmed | 2.35e-05 | 17 | 15 | 2 | 28291835 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 2.37e-05 | 411 | 15 | 4 | 35182466 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 2.46e-05 | 134 | 15 | 3 | 25452129 | |
| Pubmed | 2.70e-05 | 425 | 15 | 4 | 24999758 | ||
| Pubmed | Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode. | 2.96e-05 | 19 | 15 | 2 | 27626385 | |
| Pubmed | 2.96e-05 | 19 | 15 | 2 | 16204234 | ||
| Pubmed | 3.28e-05 | 20 | 15 | 2 | 11877444 | ||
| Pubmed | 3.63e-05 | 21 | 15 | 2 | 19596656 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 3.67e-05 | 954 | 15 | 5 | 36373674 | |
| Pubmed | 3.95e-05 | 157 | 15 | 3 | 30186101 | ||
| Pubmed | 3.99e-05 | 22 | 15 | 2 | 11867769 | ||
| Pubmed | 5.18e-05 | 25 | 15 | 2 | 36708875 | ||
| Pubmed | Subunit architecture and functional modular rearrangements of the transcriptional mediator complex. | 5.61e-05 | 26 | 15 | 2 | 24882805 | |
| Pubmed | Novel critical role of a human Mediator complex for basal RNA polymerase II transcription. | 5.61e-05 | 26 | 15 | 2 | 11559591 | |
| Pubmed | 5.61e-05 | 26 | 15 | 2 | 34506481 | ||
| Pubmed | 7.00e-05 | 29 | 15 | 2 | 14638676 | ||
| Pubmed | 8.02e-05 | 31 | 15 | 2 | 23322298 | ||
| Pubmed | TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains. | 9.10e-05 | 33 | 15 | 2 | 33567268 | |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 9.10e-05 | 33 | 15 | 2 | 26864203 | |
| Pubmed | 9.66e-05 | 34 | 15 | 2 | 15989967 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.07e-04 | 220 | 15 | 3 | 35785414 | |
| Pubmed | 1.10e-04 | 222 | 15 | 3 | 37071664 | ||
| Pubmed | 1.27e-04 | 39 | 15 | 2 | 38690566 | ||
| Pubmed | 1.36e-04 | 645 | 15 | 4 | 25281560 | ||
| Pubmed | 1.55e-04 | 43 | 15 | 2 | 36878279 | ||
| Pubmed | 1.57e-04 | 250 | 15 | 3 | 18660489 | ||
| Pubmed | 1.70e-04 | 45 | 15 | 2 | 33596420 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 1.81e-04 | 695 | 15 | 4 | 23602568 | |
| Pubmed | 1.86e-04 | 47 | 15 | 2 | 15175163 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.26e-04 | 283 | 15 | 3 | 30585729 | |
| Pubmed | 2.45e-04 | 54 | 15 | 2 | 16239144 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.73e-04 | 774 | 15 | 4 | 15302935 | |
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 2.93e-04 | 59 | 15 | 2 | 28813667 | |
| Pubmed | 3.07e-04 | 1497 | 15 | 5 | 31527615 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 4.02e-04 | 857 | 15 | 4 | 25609649 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 4.09e-04 | 861 | 15 | 4 | 36931259 | |
| Pubmed | Streamlined analysis schema for high-throughput identification of endogenous protein complexes. | 4.24e-04 | 71 | 15 | 2 | 20133760 | |
| Interaction | MED23 interactions | 3.79e-10 | 266 | 15 | 7 | int:MED23 | |
| Interaction | KLF5 interactions | 3.54e-09 | 195 | 15 | 6 | int:KLF5 | |
| Interaction | MED1 interactions | 4.92e-09 | 206 | 15 | 6 | int:MED1 | |
| Interaction | WWTR1 interactions | 9.35e-09 | 422 | 15 | 7 | int:WWTR1 | |
| Interaction | MED28 interactions | 1.66e-08 | 116 | 15 | 5 | int:MED28 | |
| Interaction | HNF4A interactions | 2.76e-08 | 275 | 15 | 6 | int:HNF4A | |
| Interaction | MED15 interactions | 3.06e-08 | 131 | 15 | 5 | int:MED15 | |
| Interaction | MED20 interactions | 1.54e-07 | 181 | 15 | 5 | int:MED20 | |
| Interaction | AR interactions | 1.58e-07 | 992 | 15 | 8 | int:AR | |
| Interaction | MED13L interactions | 1.87e-07 | 71 | 15 | 4 | int:MED13L | |
| Interaction | MED11 interactions | 1.87e-07 | 71 | 15 | 4 | int:MED11 | |
| Interaction | MED18 interactions | 3.20e-07 | 81 | 15 | 4 | int:MED18 | |
| Interaction | YAP1 interactions | 3.38e-07 | 1095 | 15 | 8 | int:YAP1 | |
| Interaction | MED30 interactions | 3.70e-07 | 84 | 15 | 4 | int:MED30 | |
| Interaction | MED22 interactions | 3.88e-07 | 85 | 15 | 4 | int:MED22 | |
| Interaction | MED13 interactions | 4.07e-07 | 86 | 15 | 4 | int:MED13 | |
| Interaction | MED7 interactions | 5.34e-07 | 92 | 15 | 4 | int:MED7 | |
| Interaction | SOX9 interactions | 6.61e-07 | 97 | 15 | 4 | int:SOX9 | |
| Interaction | MED6 interactions | 7.77e-07 | 101 | 15 | 4 | int:MED6 | |
| Interaction | MED10 interactions | 8.09e-07 | 102 | 15 | 4 | int:MED10 | |
| Interaction | MED29 interactions | 8.09e-07 | 102 | 15 | 4 | int:MED29 | |
| Interaction | MED27 interactions | 8.09e-07 | 102 | 15 | 4 | int:MED27 | |
| Interaction | CEBPA interactions | 9.03e-07 | 1245 | 15 | 8 | int:CEBPA | |
| Interaction | MED19 interactions | 9.44e-07 | 106 | 15 | 4 | int:MED19 | |
| Interaction | MED26 interactions | 9.80e-07 | 107 | 15 | 4 | int:MED26 | |
| Interaction | MED9 interactions | 1.02e-06 | 108 | 15 | 4 | int:MED9 | |
| Interaction | MRGBP interactions | 1.06e-06 | 109 | 15 | 4 | int:MRGBP | |
| Interaction | TBXT interactions | 1.35e-06 | 116 | 15 | 4 | int:TBXT | |
| Interaction | TP53BP1 interactions | 1.36e-06 | 533 | 15 | 6 | int:TP53BP1 | |
| Interaction | POLR2A interactions | 1.40e-06 | 536 | 15 | 6 | int:POLR2A | |
| Interaction | MED16 interactions | 1.55e-06 | 120 | 15 | 4 | int:MED16 | |
| Interaction | ACTL6A interactions | 1.56e-06 | 289 | 15 | 5 | int:ACTL6A | |
| Interaction | MED8 interactions | 1.60e-06 | 121 | 15 | 4 | int:MED8 | |
| Interaction | MED31 interactions | 1.83e-06 | 125 | 15 | 4 | int:MED31 | |
| Interaction | MED24 interactions | 2.01e-06 | 128 | 15 | 4 | int:MED24 | |
| Interaction | PML interactions | 2.07e-06 | 933 | 15 | 7 | int:PML | |
| Interaction | FOS interactions | 2.28e-06 | 312 | 15 | 5 | int:FOS | |
| Interaction | NCOA2 interactions | 2.95e-06 | 141 | 15 | 4 | int:NCOA2 | |
| Interaction | NCOA6 interactions | 3.30e-06 | 145 | 15 | 4 | int:NCOA6 | |
| Interaction | KAT5 interactions | 4.46e-06 | 358 | 15 | 5 | int:KAT5 | |
| Interaction | MED21 interactions | 4.76e-06 | 159 | 15 | 4 | int:MED21 | |
| Interaction | DCAF7 interactions | 5.10e-06 | 368 | 15 | 5 | int:DCAF7 | |
| Interaction | MED12L interactions | 5.30e-06 | 47 | 15 | 3 | int:MED12L | |
| Interaction | RXRA interactions | 6.06e-06 | 169 | 15 | 4 | int:RXRA | |
| Interaction | MED14 interactions | 6.35e-06 | 171 | 15 | 4 | int:MED14 | |
| Interaction | EGR2 interactions | 6.35e-06 | 171 | 15 | 4 | int:EGR2 | |
| Interaction | RB1 interactions | 7.12e-06 | 394 | 15 | 5 | int:RB1 | |
| Interaction | MED12 interactions | 7.12e-06 | 176 | 15 | 4 | int:MED12 | |
| Interaction | FHL2 interactions | 7.29e-06 | 396 | 15 | 5 | int:FHL2 | |
| Interaction | EP400 interactions | 8.49e-06 | 184 | 15 | 4 | int:EP400 | |
| Interaction | CCNC interactions | 9.24e-06 | 188 | 15 | 4 | int:CCNC | |
| Interaction | E2F1 interactions | 1.18e-05 | 200 | 15 | 4 | int:E2F1 | |
| Interaction | MED17 interactions | 1.23e-05 | 202 | 15 | 4 | int:MED17 | |
| Interaction | HOXA10 interactions | 1.23e-05 | 62 | 15 | 3 | int:HOXA10 | |
| Interaction | FEV interactions | 1.25e-05 | 203 | 15 | 4 | int:FEV | |
| Interaction | NUMA1 interactions | 1.65e-05 | 469 | 15 | 5 | int:NUMA1 | |
| Interaction | CDK8 interactions | 1.78e-05 | 222 | 15 | 4 | int:CDK8 | |
| Interaction | EPC1 interactions | 2.75e-05 | 81 | 15 | 3 | int:EPC1 | |
| Interaction | CRX interactions | 3.02e-05 | 254 | 15 | 4 | int:CRX | |
| Interaction | CPSF1 interactions | 3.06e-05 | 255 | 15 | 4 | int:CPSF1 | |
| Interaction | INTS9 interactions | 3.18e-05 | 85 | 15 | 3 | int:INTS9 | |
| Interaction | SELENOP interactions | 3.40e-05 | 12 | 15 | 2 | int:SELENOP | |
| Interaction | ESRRB interactions | 3.40e-05 | 262 | 15 | 4 | int:ESRRB | |
| Interaction | CDK19 interactions | 3.52e-05 | 88 | 15 | 3 | int:CDK19 | |
| Interaction | TERF2IP interactions | 3.62e-05 | 552 | 15 | 5 | int:TERF2IP | |
| Interaction | RBM14 interactions | 3.65e-05 | 553 | 15 | 5 | int:RBM14 | |
| Interaction | DYRK1B interactions | 3.90e-05 | 91 | 15 | 3 | int:DYRK1B | |
| Interaction | ASCL2 interactions | 4.01e-05 | 13 | 15 | 2 | int:ASCL2 | |
| Interaction | MED25 interactions | 4.16e-05 | 93 | 15 | 3 | int:MED25 | |
| Interaction | SLX4 interactions | 4.29e-05 | 572 | 15 | 5 | int:SLX4 | |
| Interaction | ADAR interactions | 4.79e-05 | 286 | 15 | 4 | int:ADAR | |
| Interaction | RBBP5 interactions | 4.86e-05 | 287 | 15 | 4 | int:RBBP5 | |
| Interaction | TFCP2L1 interactions | 5.01e-05 | 99 | 15 | 3 | int:TFCP2L1 | |
| Interaction | QSER1 interactions | 5.17e-05 | 100 | 15 | 3 | int:QSER1 | |
| Interaction | HCFC1 interactions | 5.27e-05 | 293 | 15 | 4 | int:HCFC1 | |
| Interaction | CREBBP interactions | 5.35e-05 | 599 | 15 | 5 | int:CREBBP | |
| Interaction | HSF1 interactions | 5.79e-05 | 609 | 15 | 5 | int:HSF1 | |
| Interaction | CSTF2T interactions | 5.97e-05 | 105 | 15 | 3 | int:CSTF2T | |
| Interaction | KHSRP interactions | 6.39e-05 | 308 | 15 | 4 | int:KHSRP | |
| Interaction | DCAF12 interactions | 6.50e-05 | 108 | 15 | 3 | int:DCAF12 | |
| Interaction | KMT2A interactions | 6.89e-05 | 314 | 15 | 4 | int:KMT2A | |
| Interaction | TBR1 interactions | 7.44e-05 | 113 | 15 | 3 | int:TBR1 | |
| Interaction | TFAP2A interactions | 7.63e-05 | 114 | 15 | 3 | int:TFAP2A | |
| Interaction | RUNX1 interactions | 7.78e-05 | 324 | 15 | 4 | int:RUNX1 | |
| Interaction | ETS1 interactions | 9.11e-05 | 121 | 15 | 3 | int:ETS1 | |
| Interaction | RUNX2 interactions | 1.03e-04 | 126 | 15 | 3 | int:RUNX2 | |
| Interaction | VDR interactions | 1.05e-04 | 127 | 15 | 3 | int:VDR | |
| Interaction | DDB1 interactions | 1.10e-04 | 697 | 15 | 5 | int:DDB1 | |
| Interaction | TCEA1 interactions | 1.15e-04 | 131 | 15 | 3 | int:TCEA1 | |
| Interaction | CXXC1 interactions | 1.18e-04 | 132 | 15 | 3 | int:CXXC1 | |
| Interaction | PAX6 interactions | 1.25e-04 | 366 | 15 | 4 | int:PAX6 | |
| Interaction | CTBP2 interactions | 1.30e-04 | 370 | 15 | 4 | int:CTBP2 | |
| Interaction | RAD50 interactions | 1.31e-04 | 371 | 15 | 4 | int:RAD50 | |
| Interaction | RBM27 interactions | 1.32e-04 | 137 | 15 | 3 | int:RBM27 | |
| Interaction | CSTF3 interactions | 1.37e-04 | 139 | 15 | 3 | int:CSTF3 | |
| Interaction | TLE3 interactions | 1.38e-04 | 376 | 15 | 4 | int:TLE3 | |
| Interaction | TLE6 interactions | 1.54e-04 | 25 | 15 | 2 | int:TLE6 | |
| Interaction | VPS72 interactions | 1.59e-04 | 146 | 15 | 3 | int:VPS72 | |
| Interaction | RPRD2 interactions | 1.59e-04 | 146 | 15 | 3 | int:RPRD2 | |
| Interaction | CPSF3 interactions | 1.59e-04 | 146 | 15 | 3 | int:CPSF3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q25 | 1.55e-03 | 180 | 15 | 2 | chr3q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 4.06e-03 | 294 | 15 | 2 | chr1p34 | |
| GeneFamily | Cyclins|Mediator complex | 6.59e-07 | 33 | 10 | 3 | 1061 | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 1.17e-05 | 135 | 15 | 3 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.36e-04 | 121 | 15 | 2 | 05c40fd39e6b6275f35aaad835f95a81fcbb0990 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-03 | 144 | 15 | 2 | f6061dd965a2b2fe6ad864f8aecc06d2e74881ce | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D175|Adult / Lineage, Cell type, age group and donor | 1.13e-03 | 150 | 15 | 2 | b0b6ba3686d3eb8a9b249d30be14111de3b893be | |
| ToppCell | Adult-Epithelial-basal_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.17e-03 | 153 | 15 | 2 | 9ee3e7f3f19a2474283c1c79045269686f35a541 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-03 | 153 | 15 | 2 | 82b77c8bae49dd63b8f10eb67df66ca71d0bb315 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-03 | 155 | 15 | 2 | 9f937ae48767fdcf1a944af4de0530d9c0ab441d | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l26|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-03 | 156 | 15 | 2 | da5cfa8fa9595613f04ce9511f8b42bad34d995a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.26e-03 | 159 | 15 | 2 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-03 | 162 | 15 | 2 | 86a0b9dabd150dc993bfc0f3344804de7f8e4042 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-03 | 163 | 15 | 2 | 2d6fd2562d78be9f83fa35d811eb7e27eb8cc5d1 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.33e-03 | 163 | 15 | 2 | 218b9ba099cb27aa91c6b73bf89b44895f5dddc3 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-03 | 165 | 15 | 2 | e2a70dd5870fe8708bf630ed3e6eb3f295df0cdf | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-03 | 169 | 15 | 2 | bca5322880c09b78ef10d9dda6420a80c1ba7e62 | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 1.46e-03 | 171 | 15 | 2 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-03 | 172 | 15 | 2 | e39ea2f4edbf36ebf9604fa6f9349081859c596c | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.48e-03 | 172 | 15 | 2 | ebeda7ef181cac0109be750a98e7589c615d2724 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-03 | 172 | 15 | 2 | 875ea290840e835952623b905eb610f3c71456d2 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-03 | 172 | 15 | 2 | bcc50bed47465daa953ba91f17d1ee4c947ab461 | |
| ToppCell | mild_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 1.48e-03 | 172 | 15 | 2 | dab2f1a05c7df58d9387b13271b3f1f1583f9ac3 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-03 | 172 | 15 | 2 | 1bbf5ed7d13635f9a7e528060341e0652699bd7c | |
| ToppCell | COPD-Myeloid-pDC|World / Disease state, Lineage and Cell class | 1.51e-03 | 174 | 15 | 2 | be8227398300711ccda5ecc41ad34064bb246b19 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.51e-03 | 174 | 15 | 2 | ab654e87c7eab7f33adc61be7a86da5c4d88008d | |
| ToppCell | BAL-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.51e-03 | 174 | 15 | 2 | d9bccff5258c4277bdd1edbd87e17c327ec125e8 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.51e-03 | 174 | 15 | 2 | 2453419842fd22d066631615403393bfe4449bb8 | |
| ToppCell | Adult-Epithelial-basal_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.51e-03 | 174 | 15 | 2 | a4f98afe7d1cc2617f6f7bc8092c41df57474b30 | |
| ToppCell | BAL-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.53e-03 | 175 | 15 | 2 | 6d5bdfbe53608e01c3845ecd908ca6d0fecc58f8 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.53e-03 | 175 | 15 | 2 | 37c2d4e0b6e9a3171931797ce9a54f3347288e57 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.53e-03 | 175 | 15 | 2 | 9d6135e183179968555670abec39dff9da2c3219 | |
| ToppCell | IPF-Myeloid-pDC|World / Disease state, Lineage and Cell class | 1.53e-03 | 175 | 15 | 2 | a06785a4ded01adfd29ca4c20f7759eccbe274cb | |
| ToppCell | mild_COVID-19-pDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.53e-03 | 175 | 15 | 2 | b87f279a7519710146c49d6acccb0adedc195965 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.53e-03 | 175 | 15 | 2 | 6839ee3bb4457d13cb08ca8eb79ae33ddd256783 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.56e-03 | 177 | 15 | 2 | c5e829bc4594761666d65cace5a9c5d19c16f187 | |
| ToppCell | Control-Myeloid-pDC|Control / Disease state, Lineage and Cell class | 1.56e-03 | 177 | 15 | 2 | 3940663bb5b45b2ca9f772550380a516c53e410b | |
| ToppCell | Adult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.56e-03 | 177 | 15 | 2 | d652b7d84fe6aa38319d8d5adc72c70441bd0088 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-03 | 177 | 15 | 2 | f28243b51be104cb3adcde63f03fc2206ed3121e | |
| ToppCell | COPD-Myeloid-pDC|COPD / Disease state, Lineage and Cell class | 1.56e-03 | 177 | 15 | 2 | 415aa023195a7f961c09529f65cdcc7bb90eaf5d | |
| ToppCell | IPF-Myeloid-pDC|IPF / Disease state, Lineage and Cell class | 1.58e-03 | 178 | 15 | 2 | 8d9e28492e1f157bac3308aa947fd864ca16d277 | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 1.58e-03 | 178 | 15 | 2 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | COPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 1.60e-03 | 179 | 15 | 2 | 29b058c5e33fda9f0d738c074bdb67ff16b9b6d5 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-03 | 180 | 15 | 2 | 5c649e2b3f5a53c0040b69df6e289fb3427ef2db | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.63e-03 | 181 | 15 | 2 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.65e-03 | 182 | 15 | 2 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | Healthy/Control-pDC|World / Disease group and Cell class | 1.65e-03 | 182 | 15 | 2 | 97e0eee10905f2cf2bebb09e474629fc224f4397 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-03 | 182 | 15 | 2 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | 18-Distal-Immune-Hematopoietic,_B_Cells|Distal / Age, Tissue, Lineage and Cell class | 1.65e-03 | 182 | 15 | 2 | cd0b9f0a25147ec3bc1e32d698511d1c3b33891f | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 1.67e-03 | 183 | 15 | 2 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-03 | 183 | 15 | 2 | df6fd0927b6e4cf9a1583969a68096e4bccfbace | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-03 | 183 | 15 | 2 | 3b123571e10c132227aff65648b4b3c6acb4bd00 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.70e-03 | 185 | 15 | 2 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.70e-03 | 185 | 15 | 2 | 3091870a5bf8ecb963e560b47c8502bae367416c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.70e-03 | 185 | 15 | 2 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-03 | 186 | 15 | 2 | 0096a61b1841784c913752b4f3639200446cc02c | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-03 | 186 | 15 | 2 | 9e159ad7289dcae2ec7ce655df746f46801b81d3 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.72e-03 | 186 | 15 | 2 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 3'_v3-blood-Hematopoietic_progenitors-Progenitor_Erythro-Mega|blood / Manually curated celltypes from each tissue | 1.72e-03 | 186 | 15 | 2 | 59c115bbbb4bca4ad80be1809d8a0422b8438ea3 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-03 | 186 | 15 | 2 | 6345777847960c71a2ba3ce5a49c72c34ebd0e73 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-03 | 187 | 15 | 2 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | Healthy_donor-pDC|World / disease group, cell group and cell class (v2) | 1.74e-03 | 187 | 15 | 2 | aa2cc54487d3c5045ac0c93560944c5a55878e27 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.76e-03 | 188 | 15 | 2 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-03 | 188 | 15 | 2 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-03 | 189 | 15 | 2 | 3e8e30160a8d6f531ff743cb5918c9e79481f1bd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-03 | 189 | 15 | 2 | 851f8144aed5c7f80302911cd6b03f14bde7b56d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-03 | 189 | 15 | 2 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 1.80e-03 | 190 | 15 | 2 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-03 | 190 | 15 | 2 | 1c5cf933ce71fed5638b9ef31eb81f6c2b6dadbc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-03 | 190 | 15 | 2 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.82e-03 | 191 | 15 | 2 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | facs-Pancreas-Exocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-03 | 193 | 15 | 2 | c3161a14a40323a58aa202c8a1d6ea0e9c2b9814 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.85e-03 | 193 | 15 | 2 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.87e-03 | 194 | 15 | 2 | 7c6c0376603e5fcb64814fd6204d153629c2fbf5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-03 | 194 | 15 | 2 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-03 | 194 | 15 | 2 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.87e-03 | 194 | 15 | 2 | 0cd4363627acd419e00d6d32f6dce10430aa6487 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS-RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.87e-03 | 194 | 15 | 2 | a58841b34efe673671a9a059238e044a7254b279 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-03 | 195 | 15 | 2 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-03 | 195 | 15 | 2 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-03 | 195 | 15 | 2 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-03 | 196 | 15 | 2 | 3dc6394c5de1f875a19ad0e8799827fad29f8f02 | |
| ToppCell | Mesenchymal_cells-Myofibroblasts|World / Lineage and Cell class | 1.91e-03 | 196 | 15 | 2 | 2c0f429ae18c2df05c33ddf58dcc2c94b819b9a1 | |
| ToppCell | mild-pDC|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.93e-03 | 197 | 15 | 2 | 15230a54fa5903dd728de1a0ad633bd2d2c7a04d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-03 | 197 | 15 | 2 | 27c044833e471a312a572e0b1c83e4bc8a36e896 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal-GABAergic_neurons|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.93e-03 | 197 | 15 | 2 | 21f3ef7c3c10b4e3adde431097dfdcd513c74a95 | |
| ToppCell | mild-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.93e-03 | 197 | 15 | 2 | 0cb00daa6943f7a7fb34a8fdf51188646af65686 | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.93e-03 | 197 | 15 | 2 | 3a5908deb5c5a2bf06019a102fb1652233cf2a2a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.95e-03 | 198 | 15 | 2 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.95e-03 | 198 | 15 | 2 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-IN_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.95e-03 | 198 | 15 | 2 | 3811d9e3e54bbe8b208c591697e43b55ab5bbf0e | |
| ToppCell | severe-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.95e-03 | 198 | 15 | 2 | 3c4820a8391088682fb3e47b914f872533bae227 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-03 | 198 | 15 | 2 | 5e70246a9ce199cb2fb5379912b8ab59456219e4 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-03 | 199 | 15 | 2 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | LPS_only-Hematopoietic_Lymphocytic-B_cells-B-cells|LPS_only / Treatment groups by lineage, cell group, cell type | 1.97e-03 | 199 | 15 | 2 | 7c297a36af047fe47412695e82320cec8a4be83c | |
| ToppCell | LPS_IL1RA-Hematopoietic_Lymphocytic-B_cells-B-cells|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.97e-03 | 199 | 15 | 2 | 0eb8c72edcd34fe0f7ab9438c9c872d63576ef3a | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Lymphocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.97e-03 | 199 | 15 | 2 | 5611b9e405a685a7a099d2f2d21dee3a939c2911 | |
| ToppCell | LPS_only-Hematopoietic_Lymphocytic-B_cells|LPS_only / Treatment groups by lineage, cell group, cell type | 1.97e-03 | 199 | 15 | 2 | fce4dc28547ae28b99ea9cf7e27c66d6a108fce5 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Lymphocytic-B_cells|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.97e-03 | 199 | 15 | 2 | 2cdc8ae6357723b9e7c0c66be656e6f748a6aa2d | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Lymphocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.97e-03 | 199 | 15 | 2 | 333e472c82df659ac9b235285eafe39109da7940 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Lymphocytic-B_cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.99e-03 | 200 | 15 | 2 | d124acbe5d46220850fe485ed78f032daddca5b1 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Lymphocytic-B_cells-B-cells|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.99e-03 | 200 | 15 | 2 | 4c8007a158f0f6b6fa259b25d2387b648bb2fc0d | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Lymphocytic-B_cells-B-cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.99e-03 | 200 | 15 | 2 | c07e37db9d50b91378d9c8355168745560cdbd25 | |
| Drug | AC1L9FY1 | 4.80e-07 | 101 | 15 | 4 | CID000444218 | |
| Disease | colon cancer (is_implicated_in) | 1.50e-04 | 36 | 15 | 2 | DOID:219 (is_implicated_in) | |
| Disease | irritability measurement | 7.82e-04 | 82 | 15 | 2 | EFO_0009594 | |
| Disease | sodium measurement | 1.23e-03 | 103 | 15 | 2 | EFO_0009282 | |
| Disease | Intellectual Disability | 1.37e-03 | 447 | 15 | 3 | C3714756 | |
| Disease | puberty onset measurement | 1.80e-03 | 125 | 15 | 2 | EFO_0005677 | |
| Disease | tea consumption measurement | 1.92e-03 | 129 | 15 | 2 | EFO_0010091 | |
| Disease | Vertigo | 2.22e-03 | 139 | 15 | 2 | HP_0002321 | |
| Disease | osteoarthritis, knee | 2.86e-03 | 158 | 15 | 2 | EFO_0004616 | |
| Disease | post-traumatic stress disorder | 4.62e-03 | 202 | 15 | 2 | EFO_0001358 | |
| Disease | risk-taking behaviour | 6.23e-03 | 764 | 15 | 3 | EFO_0008579 | |
| Disease | red blood cell density measurement | 9.20e-03 | 880 | 15 | 3 | EFO_0007978 | |
| Disease | neuroticism measurement | 1.01e-02 | 909 | 15 | 3 | EFO_0007660 | |
| Disease | vitamin D measurement | 1.23e-02 | 336 | 15 | 2 | EFO_0004631 | |
| Disease | grip strength measurement | 1.33e-02 | 350 | 15 | 2 | EFO_0006941 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQGVHSNPAMQNMNP | 2121 | Q09472 | |
| PTSQLQAQGQMQTQA | 2891 | Q96L91 | |
| QAQGQMQTQAPQPAQ | 2896 | Q96L91 | |
| MSTTQAQAQPQPANA | 26 | O60885 | |
| GSNVSMNQQNPQAPQ | 216 | P33240 | |
| SAMVGQSQQQPPQQQ | 511 | Q9UBL0 | |
| TQMPLQQTSQQQAGS | 1946 | Q86YW9 | |
| QAMNSGSPAPQSNQV | 1346 | Q9ULK4 | |
| NPMPQSQQGTMFQSQ | 1221 | O94916 | |
| ASSPTVNQTQQQMGP | 441 | Q14686 | |
| MNNQQAGTSGVPQVN | 591 | Q14686 | |
| GQSQNPNQNQSQNPN | 536 | Q96MM7 | |
| HQQNGPAQNQMQVPS | 41 | O95487 | |
| QQVQMAGAPSQQQPM | 221 | Q96G25 | |
| EAQSSSQLQPNGMQN | 371 | Q02446 | |
| SQLQPNGMQNAQDQS | 376 | Q02446 | |
| PPSQNNAANISMVQA | 856 | Q5VZL5 | |
| QQQMAPSTLSQQNHP | 196 | Q9GZV5 | |
| ENAGQTPMNINPQQT | 341 | Q9GZV5 |